What is Patent Evergreening and Why is it Controversial?
Patent evergreening refers to the practice of making minor modifications to existing drugs to extend their patent protection beyond the original expiration date. While this can lead to genuine improvements, it is often criticized as a strategy to maintain market exclusivity and keep drug prices high, delaying the entry of cheaper generics into the market.
